Description

A spot treatment that corrects and moisturises for clearer skin in 4 weeks. Now with broad spectrum protection against UVA, UVB and pollution.

SPECIFICALLY FORMULATED FOR Specifically formulated for oily and acne-prone skin in both adults and teenagers. A dual action daily gel-moisturiser that minimises the appearance of spots and blackheads, limits shine and reduces inflammation in order to prevent red and brown pigmentation marks that are sometimes left by spots. Provides immediate protection from UVA and UVB rays. Helps shield the skin from the damaging effects of pollution and infrared over time. Keeps skin hydrated for 24 hours. Clearer skin in 4 weeks. Suitable for even sensitive skin.

Anti-blemish treatment that corrects and moisturises oily and acne-prone skin Noticeably reduces spots, controls shine and reduces the appearance of dark marks With broad spectrum UV protection

ACTIVE INGREDIENTS Enriched with LHA to exfoliate the skin, unclog blocked pores and minimise the appearance of scarring. Also contains niacinamide to help reduce redness and size of spots, as well as soothe irritation caused by spots. Enriched with [ACTIVE SHIELD XL PROTECT] with SPF 30, PPD (UVA protection) and Carnosine, an anti-oxidant, that helps shield from damage caused by pollution.

DERMATOLOGICALLY TESTED Effaclar has been rigorously dermatologically tested to ensure it is suitable for use on even the most sensitive skin. 9/10 dermatologists would recommend La Roche-Posay Effaclar for oily, spot-prone skin*

MINIMALIST HYPO-ALLERGENIC FORMULA The minimalist formula contains no parabens, no preservatives no soap, no colourants and no lanolin. It is hypoallergenic and non-comedogenic (won’t block pores). *Survey of 249 dermatologists at the British Association of Dermatologist’s conference, July 2015. Survey conducted by La Roche-Posay

How to use Using a pea size amount, apply to the whole face and neck in circular motions. Avoid eye contour. For sun protection throughout the day, top up with a facial sunscreen.